Armstrong Advisory Group’s Nu Skin NUS Stock Holding History

Armstrong Advisory Group’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-94	Closed	-$1.99K	–	815
2023 Q3	$1.99K	Buy	+94	New	+$2.44K	﹤0.01%	780

Other funds holding NUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Armstrong Advisory Group's NUS Position: Q4 2023 in Review

Armstrong Advisory Group sold out of Nu Skin (NUS) in Q4 2023, closing a stake of 94 shares — an estimated $1.99K sold.

Armstrong Advisory Group first reported a position in NUS in Q3 2023 and held it in 1 quarter. The position peaked at $1.99K in Q3 2023. 212 funds tracked by Wall St. Rank hold NUS as of Q4 2023.

Armstrong Advisory Group reported no remaining Nu Skin position as of Q4 2023 after selling out during the quarter.
Armstrong Advisory Group sold 94 Nu Skin shares in Q4 2023, an estimated $1.99K.
Armstrong Advisory Group first reported a position in Nu Skin in Q3 2023 and held it in 1 quarter.
Armstrong Advisory Group's Nu Skin position peaked at $1.99K in Q3 2023.
212 funds tracked by Wall St. Rank held Nu Skin as of Q4 2023.

Based on Armstrong Advisory Group's 13F filing for Q4 2023, filed 17 Jan 2024.